# Elzonris

NDC: 72187-0401
Generic name: tagraxofusp
Labeler / Manufacturer: Stemline Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20190118

FDA application: BLA761116

## Active ingredients

- TAGRAXOFUSP: 1000 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72187-0401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72187-0401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80eb1080-fe20-4af0-b2a5-a67999923fa8